Pegylated Interferon/Ribavirin dual therapy in patients with chronic Hepatitis C: results of 323 cases

Journal Title: Journal of Microbiology and Infectious Diseases - Year 2015, Vol 5, Issue 4

Abstract

Objective: The combination of pegylated interferon-α (PEG-IFN) and ribavirin has become a mainstay in the treatment of chronic hepatitis C (CHC). We aimed to evaluate the efficacy of this treatment in patients with CHC, while considering new approaches. Methods: A total of 323 patients with CHC underwent PEG-IFN and ribavirin combination treatment from the 3 centers (2 in Ordu and 1 in Samsun provinces) in Middle Black Sea region between the years of 2003-2013. Results: Of the patients, 208 (67%) were female and had a mean age 54 ± 10 years (median: 54; 19-70). Genotyping was performed in 163 patients, and 161 patients (98.8%) revealed genotype 1. Sustained virologic response (SVR) and the end of treatment response rates were 58.3% and 75.6%, respectively. In patients with rapid virological response, the SVR rate was 85.1%, whereas in patients with a HCV RNA level less than 800,000 IU/ml, the SVR rate was 71.2%. The SVR rates were found to be higher in patients who developed hypothyroidism, which was statistically significant (p = 0.03). The most frequent side effect was anemia, followed by thrombocytopenia, fatigue, and loss of appetite. Conclusion: Presently, PEG-IFN/ribavirin is still an option in the treatment of certain patient populations even after the consideration of newer treatment methods. J Microbiol Infect Dis 2015;5(4): 151-155 Key words: Pegylated interferon, ribavirin, therapy, hepatitis C

Authors and Affiliations

Aynur Atilla, Emel Duyar, Fatih Bostancı, S. Sırrı Kılıç

Keywords

Related Articles

Nörovirus kaynaklı bir gastroenterit salgını

Amaç: Bu çalışmada içme suyu kaynaklı bir norovirüs salgınının epidemiyolojik özelliklerini ve salgın kontrol çalışmalarını sunmayı amaçladık. Yöntemler:Bu çalışmada Nisan 2010’da Isparta Keçiborlu ilçesinde yaşanan sal...

Non-typhoidal Salmonella isolates from livestock and food samples, Kolkata, India

ABSTRACT Objective: Non-typhoidal Salmonella (NTS) is a major foodborne pathogen in both developed and developing countries. The study was undertaken to determine the prevalence, serotype distribution and antimicrobial r...

Leptomeningeal Carcinomatosis Originated from Breast Cancer  

Malignant melanoma, breast cancer and lung cancer are the most causative malignancies of leptomeningeal carsinomatosis (LC). A LC case that was previously diagnosed as tuberculosis meningitis, is presented here to e...

Kronik Hepatit C’li hastalarda pegylated ınterferon/ribavirin ikili tedavisi: 323 hastanın sonuçları

Amaç: Pegile interferon-α (PEG-IFN) ve ribavirin kombinasyonu Kronik Hepatit C (KHC) tedavisinde standarttır. Bu tedavinin yeni yaklaşımlar eşliğinde KHC’li hastalarda etkinliğinin araştırılması amaçlandı. Yöntemler: Or...

Persistent colonization of Helicobacter pylori in human gut induces gastroduodenal diseases

Helicobacter pylori are gut bacteria colonize in the epithelial cell lining of the stomach and persist there for long du­ration. Around two-thirds of the world’s populations are infected with H. pylori and cause more th...

Download PDF file
  • EP ID EP90364
  • DOI 10.5799/ahinjs.02.2015.04.0196
  • Views 144
  • Downloads 0

How To Cite

Aynur Atilla, Emel Duyar, Fatih Bostancı, S. Sırrı Kılıç (2015). Pegylated Interferon/Ribavirin dual therapy in patients with chronic Hepatitis C: results of 323 cases. Journal of Microbiology and Infectious Diseases, 5(4), 151-155. https://europub.co.uk/articles/-A-90364